Climb Bio Inc (CLYM)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $583.86M
Last updated: Nov 17, 2026 at 4:29 PM ET
Climb Bio Inc (CLYM) Stock Chart
Climb Bio (CLYM) has a latest price of $9.78 on Nov 17, 2026, 46.6% below its 52-week high of $18.33. Its price rose 414.7% over the past 12 months. The month-end price fell 41.2% over the 5 years through Oct 2026, a compound annual decline of 10.1%.
Price Chart
From Aug 2021 to Oct 2026, its highest month-end close was $25.69 in Aug 2021 and its lowest $1.18 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CLYM with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLYM.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 43.6%, and over 6 months it rose 1.3%. The month-end price rose 289.7% over the 3 years through Oct 2026, a compound annual rate of 57.4%.
| Period | Change |
|---|---|
| 1 month | +0.5% |
| 3 months | -43.6% |
| 6 months | +1.3% |
| 12 months | +414.7% |
| 12 months, with dividends | +414.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +289.7% | +57.4% |
| 5 years | -41.2% | -10.1% |
Price by Year
Its best calendar year was 2025, when the price rose 122.2%, and its weakest was 2022, when it fell 64.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.25 | +156.3% |
| 2025 | $4.00 | +122.2% |
| 2024 | $1.80 | -33.3% |
| 2023 | $2.70 | -26.4% |
| 2022 | $3.67 | -64.9% |
Trading Range
The price is 13.8% below its 50-day average of $11.34 and 8.8% below its 200-day average of $10.72.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.78 | |
| 52-week high | $18.33 | -46.6% |
| 52-week low | $1.64 | +498.2% |
| 50-day average | $11.34 | -13.8% |
| 200-day average | $10.72 | -8.8% |
Price Risk
Over 3 years, its largest fall from a peak was 88.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.58 |
| Largest fall, 1 year | -50.6% |
| Largest fall, 3 years | -88.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CLYM
What is CLYM's 1-year price change?
Climb Bio's price rose 414.7% over the past 12 months. With dividends included, the 12-month total return was 414.7%.
What is CLYM's 5-year price change?
Climb Bio's month-end price fell 41.2% over the 5 years through Oct 2026, a compound annual decline of 10.1%. These figures leave out dividends.
What is CLYM's 52-week high and low?
Climb Bio's 52-week high is $18.33 and its 52-week low is $1.64. Its latest price of $9.78 on Nov 17, 2026 is 46.6% below the high.
What is CLYM's beta?
Climb Bio's 1-year beta against the S&P 500 is 1.58, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 50.6%.
Is the CLYM chart free?
Yes. Advanced Charting for CLYM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CLYM pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors